Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors

Clinical trial NCT05797168 · RECRUITING

Trial details

NCT number: NCT05797168
Sponsor: AstraZeneca
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Ovarian Cancer Lung Adenocarcinoma Endometrial Cancer Lung Squamous Cell Carcinoma

Start date: 2023-06-05
Primary completion: 2028-08-04
Enrollment: 602

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.